Avalide News
Bristol-Myers Squibb Company Reports Financial Results for the ... - PR Newswire (press release)
2006 Twelve Months Ended December 31, Pharmaceuticals Cardiovascular Plavix $4755 $3257 46 % 4060 2655 53 % 34 % Avapro/Avalide 1204 1097 10 % 692 647 7 ...
Bristol-Myers Squibb Company Reports Financial Results for the ... - PR Newswire (press release)
2006 Twelve Months Ended December 31, Pharmaceuticals Cardiovascular Plavix $4755 $3257 46 % 4060 2655 53 % 34 % Avapro/Avalide 1204 1097 10 % 692 647 7 ...
Bristol-Myers Squibb Company Reports Financial Results for the ... - CNNMoney.com
2006 Twelve Months Ended December 31, Pharmaceuticals Cardiovascular Plavix $4755 $3257 46 % 4060 2655 53 % 34 % Avapro/Avalide 1204 1097 10 % 692 647 7 ...
Bristol-Myers Squibb Company Reports Financial Results for the ... - CNNMoney.com
2006 Twelve Months Ended December 31, Pharmaceuticals Cardiovascular Plavix $4755 $3257 46 % 4060 2655 53 % 34 % Avapro/Avalide 1204 1097 10 % 692 647 7 ...
BMS and Sanofi-Aventis Hypertension Drug Approved for Additional Use - FDA news (subscription)
... initial use of their antihypertensive drug Avalide in patients with hypertension who are likely to need multiple drugs to lower their blood pressure. ...
Market Report -- In Play (BMY) - MSN Money
Bristol-Myers: FDA approves AVALIDE supplemental new drug application Sanofi-Aventis (SNY) and Bristol-Myers Squibb announces that the FDA has approved the ...
Sanofi-Aventis And Bristol-Myers Squibb Says FDA Approves SNDA For ... - RTT News
(BMY) said that they have received FDA approval for the supplemental new drug application or snda for the antihypertensive agent Avalide for initial use in ...
Sanofi-Aventis And Bristol-Myers Squibb Says FDA Approves SNDA For ... - Trading Markets (press release)
... agent Avalide for initial use in patients with hypertension who are likely to need multiple drugs to achieve their blood pressure goals. ...
BMS and Sanofi-Aventis Hypertension Drug Approved for Additional Use - FDA news (subscription)
all 2 news articles
B-MS gets approval for two sndas and an analyst upgrade - Pharma Times (subscription)
The approval came just as the FDA also approved an snda for B-MS and Sanofi-Aventis’ combination hypertension drug Avalide (irbesartan/hydrochlorothiazide). ...
Avalide RSS Feed